Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Lumateperone sNDAs Submitted for Bipolar Depression Indication
Sildenafil, Trazodone Tablets Recalled After Being Packaged Together
Hetlioz Approved for Nighttime Sleep Disturbances in Smith-Magenis Syndrome
Additional Administration Option Approved for Nuplazid Capsules
Disproportionality Signal Found for Suicidality in Finasteride Users
Fluvoxamine Evaluated in Patients With Mild COVID-19
FDA Issues Complete Response Letter for Olanzapine/Samidorphan
Review Assesses Pharmacotherapies for Adult ADHD
FDA Authorizes Digital Therapeutic for Sleep Disturbance in PTSD
Valerian Quality, Storage Issues May Affect Sleep Outcomes
Application for Long-Acting Schizophrenia Treatment Submitted
Neurologic Complications Seen in Hospitalized COVID-19 Patients
Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
Wakix Indication Expanded to Include Cataplexy Treatment
FDA Committees Vote on Novel Therapy for Schizophrenia, Bipolar I Disorder
Idiopathic Hypersomnia Study Evaluating Xywav Meets End Points
Mortality Risk Up With Newer Antipsychotic Use for Depression
FDA Requires Boxed Warning Update for Benzodiazepines